SCHEMBL6647779

SCHEMBL6647779

CC1(CCc2ccccc2)CCC1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.44
OPRL1 P41146 3/20 0.44
ALDH1A1 P00352 2/20 0.41
KDM1A O60341 2/20 0.41
MAOA P21397 2/20 0.41
MAOB P27338 2/20 0.41
SLC6A3 Q01959 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
ALOX12 P18054 1/20 0.39
CASP1 P29466 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TAAR1 Q96RJ0 2/20 0.39
ATM Q13315 1/20 0.39
BACE1 P56817 2/20 0.39
OPRD1 P41143 1/20 0.39
OPRK1 P41145 1/20 0.39
SIGMAR1 Q99720 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15355130 0.96 OPRM1 (0.44) OPRM1OPRL1ALDH1A1KDM1AMAOA
SCHEMBL18114513 0.94 OPRM1 (0.42) OPRM1OPRL1ALDH1A1KDM1AMAOA
SCHEMBL6647972 0.88 OPRM1 (0.45) OPRM1OPRL1MAOAOPRD1OPRK1
SCHEMBL13936275 0.82 ALDH1A1 (0.44) OPRM1OPRL1ALDH1A1KDM1AMAOA
SCHEMBL13936292 0.80 ALDH1A1 (0.43) OPRM1OPRL1ALDH1A1SLC6A3BACE1
SCHEMBL6672640 0.78 MAOA (0.50) OPRM1OPRL1KDM1AMAOAMAOB
SCHEMBL25340074 0.75 TDP1 (0.43) OPRM1OPRL1ALDH1A1KDM1AMAOA
SCHEMBL6647777 0.75 OPRM1 (0.44) OPRM1OPRL1ALDH1A1KDM1AMAOA
SCHEMBL4204848 0.75 OPRM1 (0.60) OPRM1OPRL1ALDH1A1KDM1AMAOA
SCHEMBL25341004 0.75 DPP4 (0.53) OPRM1OPRL1KDM1AMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465862-A1 CYCLOALKYL KETOAMIDES DERIVATIVES USEFUL AS CATHEPSIN K INHIBITORS SmithKline Beecham Corporation (US) 2004-10-13 EP claimed
WO-2003062192-A1 CYCLOALKYL KETOAMIDES DERIVATIVES USEFUL AS CATHEPSIN K INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-07-31 WO claimed
EP-1465862-A1 CYCLOALKYL KETOAMIDES DERIVATIVES USEFUL AS CATHEPSIN K INHIBITORS SmithKline Beecham Corporation (US) 2004-10-13 EP disclosed
WO-2003062192-A1 CYCLOALKYL KETOAMIDES DERIVATIVES USEFUL AS CATHEPSIN K INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-07-31 WO disclosed